Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-22-061695

Chief Scientific Officer sold 5,000 shares at $15.88 ($79,412)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Monahan Joseph Chief Scientific Officer 2022-12-15 Sale −5,000 $15.88 $79,412 96,386 D
Open-market sales · 5,000 sh · avg $15.88 · $79,412
Loading xslF345X03/doc4.xml…